PDL BioPharma, Inc. Capital expenditures

Capital expenditures of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capital expenditures growth rates and interactive chart. Capital expenditures, commonly known as Capex, are funds used by a company to acquire, upgrade, and maintain physical or intangible assets such as property, buildings, an industrial plant, technology, software or equipment. Capex is often used to undertake new projects or investments by the firm. A company must invest over its lifetime into productive assets to maintain its competitiveness and ensure its survival.


Highlights and Quick Summary

  • Capital expenditures for the quarter ending June 29, 2020 was $-142 Thousand (a 52.69% increase compared to previous quarter)
  • Year-over-year quarterly Capital expenditures decreased by -58.36%
  • Annual Capital expenditures for 2019 was $-763 Thousand (a -83.13% decrease from previous year)
  • Annual Capital expenditures for 2018 was $-4.52 Million (a 248.73% increase from previous year)
  • Annual Capital expenditures for 2017 was $-1.3 Million (a 5088.0% increase from previous year)
  • Twelve month Capital expenditures ending June 29, 2020 was $-835 Thousand (a 2.58% increase compared to previous quarter)
  • Twelve month trailing Capital expenditures increased by 116.32% year-over-year
Trailing Capital expenditures for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
$-835 Thousand $-814 Thousand $-763 Thousand $-386 Thousand
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capital expenditures of PDL BioPharma, Inc.

Most recent Capital expendituresof PDLI including historical data for past 10 years.

Interactive Chart of Capital expenditures of PDL BioPharma, Inc.

PDL BioPharma, Inc. Capital expenditures for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $-0.14 $-0.09
2019 $-0.26 $-0.34 $-0.12 $-0.04 $-0.76
2018 $0.12 $-0.73 $-2.52 $-1.4 $-4.52
2017 $-0.14 $-0.46 $-8.06 $7.36 $-1.3
2016 $-0.03 $-0.03
2015 $0.0 $-0.01 $-0.01
2014 $0.0 $-0.01 $-0.04 $-0.05
2013 $0.0 $0.0 $-0.0 $-0.0
2012 $-0.03 $0.0 $-0.01 $-0.01 $-0.05

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.